Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Isotechnika reports 12-month follow-up data from phase IIb PROMISE trial

April 22, 2009

Immuron will acquire immune modulation technology from Hadassah Medical Center

April 21, 2009

Tolarex receives approval to initiate phase I/IIa trial of a treatment for GVHD

April 21, 2009

Amgen and Epix Pharmaceuticals claim novel compounds for the treatment of autoimmune conditions

April 21, 2009

Osiris completes enrollment in phase III Prochymal trial for graft vs. host disease

April 20, 2009

Cangene to supply the U.S. Department of Defense with VIG vaccine

April 16, 2009

Celldex Therapeutics enhances immunotherapy platform

April 14, 2009

Donor lymphocyte infusion therapy increases post stem-cell transplantation survival rates

April 14, 2009

Leflunomide acts as an immunosuppressant in kidney and/or pancreas transplant patients

April 14, 2009

Allergy signs distribution agreement with Nycomed Canada for Pollinex Quattro

April 9, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...